Humana Stock Lags Behind S&P 500 Despite Sector Strength

Humana Inc. (HUM) has underperformed the broader S&P 500 (^GSPC) over the past 12 months, with a 6.3% decline in share price compared to the index’s 12.8% gain. The healthcare sector’s resilience has not fully translated to Humana’s stock performance.

• Humana (HUM) declined 6.3% over the past 12 months, compared to a 12.8% gain in the S&P 500 (^GSPC)
• Healthcare sector average return: 10.2% over the same period
• HUM's trailing P/E ratio: 15.3, below the sector average of 17.1
• Year-to-date HUM return: +1.7%, S&P 500: +4.5%
• Upcoming Q4 earnings report scheduled for April 2026
• Key risk factors include Medicare pricing pressures and enrollment growth